UroGen Pharma Ltd. (URGN)
38.26
-0.02
(-0.07%)
USD |
NASDAQ |
Oct 13, 16:00
38.26
0.00 (0.00%)
After-Hours: 19:42
UroGen Pharma Cash from Investing (Quarterly) : 1.185M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.185M |
| March 31, 2026 | -20.69M |
| December 31, 2025 | 29.90M |
| September 30, 2025 | 32.93M |
| June 30, 2025 | 28.42M |
| March 31, 2025 | -25.96M |
| December 31, 2024 | 60.37M |
| September 30, 2024 | -106.30M |
| June 30, 2024 | 11.80M |
| March 31, 2024 | 13.52M |
| December 31, 2023 | -11.04M |
| September 30, 2023 | 0.2841M |
| June 30, 2023 | 3.564M |
| March 31, 2023 | 6.27M |
| December 31, 2022 | 22.40M |
| September 30, 2022 | -34.52M |
| June 30, 2022 | -0.4543M |
| March 31, 2022 | 13.60M |
| Date | Value |
|---|---|
| December 31, 2021 | 9.256M |
| September 30, 2021 | 10.65M |
| June 30, 2021 | -30.77M |
| March 31, 2021 | 15.02M |
| December 31, 2020 | 51.71M |
| September 30, 2020 | 14.03M |
| June 30, 2020 | 17.46M |
| March 31, 2020 | 13.02M |
| December 31, 2019 | 9.764M |
| September 30, 2019 | -15.09M |
| June 30, 2019 | -143.14M |
| March 31, 2019 | -0.044M |
| December 31, 2018 | -0.2879M |
| September 30, 2018 | -0.5323M |
| June 30, 2018 | -0.757M |
| March 31, 2018 | 35.83M |
| December 31, 2017 | -37.05M |
| September 30, 2017 | -0.118M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Xencor, Inc. | 85.12M |
| MeiraGTx Holdings Plc | -23.63M |
| Insmed, Inc. | 24.51M |
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Viking Therapeutics, Inc. | 109.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.02M |
| Cash from Financing (Quarterly) | 2.186M |
| Free Cash Flow | -170.67M |
| Free Cash Flow Per Share (Quarterly) | -0.6963 |
| Free Cash Flow to Equity (Quarterly) | -34.11M |
| Free Cash Flow to Firm (Quarterly) | -19.56M |
| Free Cash Flow Yield | -9.06% |